summary maulik siddhant

Upload: ershad-shafi-ahmed

Post on 05-Apr-2018

237 views

Category:

Documents


1 download

TRANSCRIPT

  • 7/31/2019 Summary Maulik Siddhant

    1/46

    1

    !""#!""#!""#!""#

    $$%&'$%$$%&'$%$$%&'$%$$%&'$%

    ()*

    (+,)-

    (+!$%.$

    '''' (//0

    12345#.$&6%412

    $%12.78 11')!1

    9: ' ;1** > #

    '#?$$@$%

    '@1A

    BB !"" C

    12#$'D!@""&32$#""E$%5FD

    $%,#6$%7'A

    $%,# $% 'D! 3 3G . $%

    ,H@E$%51AI

    ' :@ 7 A :@

    '0I%@3J0I%I$%$A

  • 7/31/2019 Summary Maulik Siddhant

    2/46

    2

    ;0LKI$%>LI$%$

    A

    .G ;MLII$%>I$%$

    A

    ' 'D $%N

    $%2 ' 12

    $62AC12@:6O$4

    $13A

    0000

    114#6.1114#6.1114#6.1114#6.1

    ()*

    (+,)-

    ()*'

    '''' (//0

    11 8 &%'P , $ 3 6 QRS

    A ( 11 8 E$% 5 6

    122$$%A

    $ % K $ $ %

    ;9812H@I>$%

    #$%$5$1%TJ,T

    $@A

  • 7/31/2019 Summary Maulik Siddhant

    3/46

    3

    ,U$%D3'KI%T T@

    $A

    '$%L57CA

    '$%11M

  • 7/31/2019 Summary Maulik Siddhant

    4/46

    4

    12H@J=$%AC$%#Y 0

    F 6 Z :

    $%H?$$%$AR(.$:

    .$N @.$ A!Y $G$% $

    :$& C@

    # Y [ $%$ F2$%

    A

    !Y!Y!Y!Y

    ,

    JKF$%@

    ,FJL

    #Y #Y #Y #Y

    F\

    F$%@

    JKT,

    ,FJL

    !YZ F.$N$MK*Z$%@

    0 :$%LZ*$%AC

    $%#Y 0 $F.$N$L

  • 7/31/2019 Summary Maulik Siddhant

    5/46

    5

    II ** T $%( 6

    JI $%A$?$ ]$%

    A

    '$1E$%

    .G;LIII$%>M JK$%

    ;0LLI$%>ZK0K$%

    & 3$& $ &?$2 8.

    $%.2A ]E$%

    AC$%.:242#$%A

  • 7/31/2019 Summary Maulik Siddhant

    6/46

    6

    KKKK

    $%&22$%&22$%&22$%&22

    $%,$%,$%,$%,

    ()*

    (+,)-

    ()*'

    '''' (//

  • 7/31/2019 Summary Maulik Siddhant

    7/46

    7

    LLLL

    ;;;;Amoebiasis>BB$1%!>BB$1%!>BB$1%!>BB$1%!"""""""";1;1;1;1****1111****/=K/=K/=K/=K

    1N$>1N$>1N$>1N$>#$$%$1:@'2#$$%$1:@'2#$$%$1:@'2#$$%$1:@'2

    ()*D!D

    ($%*,)-

    '''' (//K

    C 7 ._ BB$1 % !"" #

    #$1 ' $% A ' 6

    H@ @@#A

    $%H JI 1

    :A

    $%@ #$1:@;1812H@/=0I6

    'W2812>0$%(A

    #$11 ;112H@/=0I6

    'W2812>K% J,6

    3A

    '#1 ;FD 8 P8 ,O W3>K

    %J,63A

    '$%JI7CA

    '$ E!

    $%@LI*ZL$%A

  • 7/31/2019 Summary Maulik Siddhant

    8/46

    8

    MMMM

    BB''BB''BB''BB'''F'F'F'F$%'$%'$%'$%'####""""""""$$$$$%&$%&$%&$%&

    ()*2#

    ($%*,)-

    '''' (//K

    2$ : A C ,

    BB''' F$%' #"" #

    C$%,#H$'D$%A@6T,H$%$58C

    ._ 76 'D$%A

    $%H LI 1 :

    A

    $%@ ;18 TH@

    ,H$%A

    1 5 ;$%^ 5> 0 , ]$$%A

    ,H@15$%A

    1 5 T # 0KI *%* 6 KII *%*

    $%CAKII*%*$%(6CA

    $%67CA

    $%2'$E!

    $%@

  • 7/31/2019 Summary Maulik Siddhant

    9/46

    9

    Maulik SiddhantZZZZ

    A Comparative study of the efficacies of Basti Karma and Agni

    Karma on Gridhrasi (Sciatica) with special reference to

    "Pratyekam Sthanadusyadi kriya vaisesyamacharet"

    Scholar (Dr. S.R. Santosh

    Guide (Prof. B.L. Gaur

    Year (1996

    Aims of this study were -(1) To describe and analyse the principle BB$%2H@'

    N'1!"";1*1*0Z=II>

    (2) To understand and explain precisely the above principle.(3) To study and evaluate the applied aspect of this principle.(4) To evaluate the clinical efficacy of Basti Karma, Agni

    Karma on Gridhrasi, on the basis at the above principle.30 patients were selected and divided into 3 groups A, B & C and

    managed by Vaitarana Basti (Chakradatta 73/32), Agni Karma & both

    Basti & Agni Karma respectively.

    Period of administration 30 days

    It was found that -

    (1) In clinical study the most successful (59.74%) group wasgroup C which was managed by both Basti Karma and Agni

    Karma i.e. both sthana oriented and dusya oriented

    approach.

  • 7/31/2019 Summary Maulik Siddhant

    10/46

    10

    (2) The group A which was managed by the sthana orientedtherapy i.e. by Agni Karma was 36.36% successful.

    (3) Group B which was managed by the dusya oriented therapyi.e. by Agni Karma was 33.33% successful which was the

    least successful.

    The highest result obtained by group C shows that Caraka's

    principle is true. But neither Basti Karma nor Agni Karma is a

    treatment for Gridhrasi roga. In Gridhrasi a multiphase approach

    of both dosa oriented and sthana oriented treatment is necessary.

    ////BBHQ12,%#12$,H ""#BBHQ12,%#12$,H""#BBHQ12,%#12$,H ""#BBHQ12,%#12$,H""#

    $$%&6',H$%$$%&6',H$%$$%&6',H$%$$%&6',H$%

    ()*'$%9

    ($%*,)-

    '''' (//M12 N , 8

    2 7 12 8 C 12 9'P

    12A ,H$

    12 A ' 6 2$G ' $ % 8

    #T$G['T 8(C

    #$% C'1 $%,#6

    A

    '$%$HT:2&Q1$'

    I8$G'/['/ 1A

  • 7/31/2019 Summary Maulik Siddhant

    11/46

    11

    1 Z,H ;#

    ,HJ,HJ?,H>6#N

    E$%

    '''' aaaa,H%4,H%4,H%4,H%4;KKI;KKI;KKI;KKI********>>>> ,H%4,H%4,H%4,H%4

    ;MI;MI;MI;MI********>>>>

    ;18

    H@I=/>

    $G 3'P ;18

    H@I=0>

    [ $5$O ;18

    H@I=0

    & $6E$$O

    E$%

    ' ' ' ' $G'$G'$G'$G' [' ['['['.G

  • 7/31/2019 Summary Maulik Siddhant

    12/46

    12

    IIII

    BB:3H!BB:3H!BB:3H!BB:3H!!!!!""#""#""#""#$$%&$$$%&$$$%&$$$%&$

    ::::'$'$'$'$

    ()*$%1

    ($%*,)-

    '''' (//M

    $%H$%,#._333D4

    1 1 6 6 # BB:3H! !""

    $'D @ 6 ' 1 8 3 4

    A

    B" K : ;& 83

    >I%0,.'3$@

    A

    B," K .$ : ' :@

    $@A'$%07CA

    B" 7$$@ 8

    @ B," 7 $ $ @

    A

    .'3$ '$&:@

    $' A

  • 7/31/2019 Summary Maulik Siddhant

    13/46

    13

    'D%6'DbT'D%6'DbT'D%6'DbT'D%6'DbTH@2H@2H@2H@2

    ()*$

    ($%*,)-

    '''' (//M

    'D% 6 'Db $ T $ %$+

    ' 1 %#@, 6 6 A

    18&$8 $?:' 88

    6'C H# %#@@

    'D%$%2,3

    C %#@ ;'D%6b>2C

    %#@ TH@E6'EH$'D$%

    '1._A

    $%H $%,# %#@ 6! 1 H$'D

    6 %#@ $1 6 TH@ .$`

    # &5 .O7 @ %#@ T

    H@ 78 T 7 6 .12 @ ' H &5 $1 6 'D% 6

    b TH@ 2 6

    'D 'D 3.#

    N7A

  • 7/31/2019 Summary Maulik Siddhant

    14/46

    14

    'D% 6 'D b TH@

    .$E''$ %56

    'D% 6 'Db

  • 7/31/2019 Summary Maulik Siddhant

    15/46

    15

    4/10) 20 ml twice a day. The treatment was given upto 5

    weeks.

    Group B : Internal and external medicine Varnya

    Mahakashaya in the form kwatha and as well as lepa.In 'A' group treated with internal medicine 58.33% patients

    were markedly improved and 25% patients were improved, only 2

    patients remained unchanged.

    In 'B' group treated with internal and external medicine

    23.07% patients were cured, 38.48% patients were markedly

    improved, 38.48% patients were improved.

    Overall satisfactory results were obtained.

    JJJJ

    $%1%#@.O7612$%1%#@.O7612$%1%#@.O7612$%1%#@.O7612

    ()*1#

    ($%*,)-

    '''' (//Z

    1 'D$?$1@

    @ . 2# 6 '

    ?$47._A

    HX!, H' %

    %#@ '^$

    @.?$ $%HC

    73A

    'E$'HC$%,# 6T

    C A # LI 1 .$` A

  • 7/31/2019 Summary Maulik Siddhant

    16/46

    16

    # 8HT @ BB"":c

    C ' [ $ $%,# 3 @

    , ^ E 1 $%H

    A

  • 7/31/2019 Summary Maulik Siddhant

    17/46

    17

    %T $%(6 3G'3

    @ '0$%CCA

    4$1 $%.

    $%5$ ''E$%

    1'8'EQRFD$(

    A $%:FD E?$ 4

    & .$8@$@!0FD $

    ?$$%A

    C 0K K II$%

    @K ZIZM$%@M MIZI$%6L LIMI$%

    @ 0 , N( 0K $ % @ 0*00

    $%$%5A

    KKKK

    BB2BB2BB2BB21![F1![F1![F1![F********************************"";1"";1"";1"";1****1111****M=M=M=M=#$'D!@D!#$'D!@D!#$'D!@D!#$'D!@D!

    133#$$%#$$%#$$%#$$%

    '2'2'2'2

    ()*5

    ($%*,)-

    (+!$%.$

    '''' (///

    6 'DS ,d- 6 +

    .2$# ' [H?$ 33#

    ;Allergic Asthma>$%1 3 ,Q1

    E$ 3 N# A 33#

  • 7/31/2019 Summary Maulik Siddhant

    18/46

    18

    $%7.2$$%'6#4&2 A

    (C$@4&27'

    H , A .: $ D ! 1 .$

    .!A#@ 0I 1 3 1

    $) E7 A ;> & Q1 ;,> $ %

    $&;J>&$&A1,D!1 ;1

    8 12H@ M=0J0 II % $% ( 6

    .'JI$% A

    0I $ % .G 6 ' ZI $ %

    $%5ALLLL

    ,($3,($3,($3,($3N$%N$%N$%N$%$%6#6$%'$%6#6$%'$%6#6$%'$%6#6$%'

    ()*1

    ($%*,)-

    (+!$%.$

    '''' (///

    $ $%' 6 HH@G :

    $2] .2$G969

    $4 ?$ 73A6 H@ #($3

    E!$%#,($3?$$%8$$%

    'P G AC._

    7T 1 2,($3N $% $%

    #2@$%11 $%,#'

    1A

  • 7/31/2019 Summary Maulik Siddhant

    19/46

    19

    JI11 16

    7 @ # $'D!@ 2@ $% ;18 TH@

    J=0> ,U $% @ T

  • 7/31/2019 Summary Maulik Siddhant

    20/46

    20

    0I

    **T$%(80$%A

    ,K TD0%T $%(8

    0$% A

    K T TD

    $%(80$%A

    '$%$1!$%E$%

    B" 0M$%

    B," J0$%B" JK$%

    TD8D$CC8

    ( %4 R 2 3 8R 2 H 8

    R 2 R 8 (

    O$$&$$%A

    ZZZZ

    BB%BB%BB%BB%((((1'12f(1'12f(1'12f(1'12f(""""""""$$%&$$%&$$%&$$%&

    ($($($($122122122122

    ()*3#%

    ($%*,)-

    ()*

    '''' (0II

    H@$'$%H@;$%>A

    CN $3F4.2$#A

  • 7/31/2019 Summary Maulik Siddhant

    21/46

    21

    ,d-6+87 # .2$#

    e8$%H@$%'

    7 $% ,d- 3 A 1 8 Y1

    4: ]+ 6 2$# 4 % 8 3

    83$%12A82$%6

    H@E$ ' ' ( $ 1

    4 A

    $%'D!JI?] E$%

    '$K?]

    , ' $K?]'3(;9.*K=KI>

    $%JI

    J1

    * $%(0* ,J* 5$'$1E!

    ,,,,

    O$A ;I0K$%> I$% I$%

    ;0LM KJ*J$% L*M$%

    ( $ 'D $ %N $%2 $

    12$628C 12 @6

    O$4$13A

  • 7/31/2019 Summary Maulik Siddhant

    22/46

    22

    ////

    BBBBBBBB!""#$'D!@H@&3!""#$'D!@H@&3!""#$'D!@H@&3!""#$'D!@H@&3

    BB,H(&$':$1""T&2BB,H(&$':$1""T&2BB,H(&$':$1""T&2BB,H(&$':$1""T&2

    ()*$'$#%

    ($%*,)-

    (+!$%.$

    '''' (0II

    H@&3 H$'D64:1#

    $%$ A$ %$3 6 $

    %A$%$%24: $

    .&$%$%2[$%$H

    A(#'$$% &C

    H 1 6 ._@ C '1

    A

    H@&30I 1B"

    6B7"$%A

    $%@ H1**I=8#\ [0%A

    $%,HI

    $%?,HL

    J

  • 7/31/2019 Summary Maulik Siddhant

    23/46

    23

    71?] $:$&$H'?$

    $%A

    T(0';0I**>I** $%(8I**

    @8

    $@(.'3

    5$$E!

    B"B"B"B"

    ?]7?]7?]7?]7

    $%$%$%$% B7"B7"B7"B7"

    ?]7?]7?]7?]7

    $%$%$%$%

    .G K KI$% 0 0I$%

  • 7/31/2019 Summary Maulik Siddhant

    24/46

    24

    0I0I0I0I

    BB$$%'3!AQ1(AA""#BB$$%'3!AQ1(AA""#BB$$%'3!AQ1(AA""#BB$$%'3!AQ1(AA""#

    $'D!@[$;$'D!@[$;$'D!@[$;$'D!@[$;>>>>#:@#:@#:@#:@#6#6#6#6

    $%1$%1$%1$%1

    ()*#%3

    (+!$%.$

    '''' (0II

    ]@@ '([$ 3

    E8 ?$ $% 'D '1A

    $%0I $12$%:A

    '#:@;'W2Z=M>

    :@

    :@3$

    T'D7662,H@

    1NGETA

    'T083$,

    $%

    0I #:@K/*IM$%

    A

    $%,# C''$$ 11:

    .$N$8 %8 N$%5 12T?$ H'D12A]1

    6@$8,7% !$%$%

    6@ % @ $ 8 6@

    A

  • 7/31/2019 Summary Maulik Siddhant

    25/46

    25

    0000

    BB'3(5H&$%'$1BB'3(5H&$%'$1BB'3(5H&$%'$1BB'3(5H&$%'$1!!!!"";"";"";"";1111****1111****M=L/>#$'D!@M=L/>#$'D!@M=L/>#$'D!@M=L/>#$'D!@

    9]19]19]19]1$$%$$%$$%$$%

    ()*'G3

    ($%*,)-

    ()*

    '''' (0II

    .2$G BB[2$GH@! ""

    8 ( 12 [ 6 '

    $ % $%H @ 1 :@ $ $

    2 $% F% 8 C._ $ 1

    A

    $% JI 1& $

    @0,66A

    K 9 ] 1 ;1NG 0=K> J %8 :@;1NG0=K>0I**$@J,A

    ,K9]1J%7'3 ,A

    $%

    .GKJ*J$%

  • 7/31/2019 Summary Maulik Siddhant

    26/46

    26

    00000000

    BB'BB'BB'BB'&&&&G""#$G""#$G""#$G""#$'D!@$% '3'D!@$%'3'D!@$%'3'D!@$%'3

    BBBBBBBB:`":`":`":`""$$%&,O"$$%&,O"$$%&,O"$$%&,O'$%'$%'$%'$%6'26'26'26'2

    ()*

    (+!$%.$

    '''' (0II0

    #1 BB' &G""&

    N# $ ' N N $ '@ ,O

    '%?1O$$%C

    &7A

    @1

  • 7/31/2019 Summary Maulik Siddhant

    27/46

    27

    0J0J0J0J

    BB'D$%(T,H("";1BB'D$%(T,H("";1BB'D$%(T,H("";1BB'D$%(T,H("";1****1111****JI=ZK>#JI=ZK>#JI=ZK>#JI=ZK>#

    $'D!@'4$!$$%&T:T[:@$'D!@'4$!$$%&T:T[:@$'D!@'4$!$$%&T:T[:@$'D!@'4$!$$%&T:T[:@

    .G,H6.E,.G,H6.E,.G,H6.E,.G,H6.E,$1$1$1$1122122122122

    ()*D!D

    ($%*,)-

    ()*,

    '''' (0II0

    '3 HT $C36

    HA C, 4.$16.,1

    .$ 3O 6 HT HH@ .#'D

    C4 @HE8 @8 $%H@ %

    6$.E,6TgT[:@.G

    ,H1A

    '4$%

    $%K**TT $1@A

    , T : T[ :@ .G ,H 0IIJII **

    TA

    . E,6 T : T[:@.G,H

    $%A

    $%M

    'E$%

  • 7/31/2019 Summary Maulik Siddhant

    28/46

    28

    &&&&

    ,,,,

    * 3%

  • 7/31/2019 Summary Maulik Siddhant

    29/46

    29

    Literary research is carried out and planned to review all

    ayurvedic texts and allied literature with modern literature to develop

    the critical view of learning methodology.

    It was found that multi disciplinary approach is necessary to

    establish the principle methods, one has to employ to support the

    existing ideas and not to replace them.

    Teaching must be simplified. Different instructional media can

    make it easy.

    Maulik Siddhant0K0K0K0K

    Comparative study of Charak's Dietary principles with ModernDietetics

    Scholar (Dr. Ajay Nawale

    Guide (Prof. B.L. Gaur

    Co-Guide (Dr. Baldev Kumar

    Year (2002

    The aim is to compare the ancient wisdom from Charaka Samhitawith its modern counterpart. So as to provide a better approach

    towards. This science of food, which is closely related to our health and

    day to day life.

    Literary research is planned to review all ayurvedic texts and

    allied literature with modern literature.

    It was found that dietetics is a science that deals with the

    adequacy of diet during normal life and modified required duringdisease condition.

    Therefore we can say that there is no basic difference in concept

    of diet therapy. The difference is within the nature of medicine and

    different dietary preparation.

  • 7/31/2019 Summary Maulik Siddhant

    30/46

    30

    0L0L0L0L

    BB4BB4BB4BB4$%2""#N2!$31$%2""#N2!$31$%2""#N2!$31$%2""#N2!$31

    66663333#6 122#6122#6122#6122

    ()*3D

    ($%*,)-

    ()*'

    '''' (0II0

    2 ^ 6 6 $%

    6C'1A$+$%5

    2& $2'P

    A 'P X! $% 5

    H 3D 8 C 'D 'P

    3A

    N$%1

    'I

    ,TM

    $%2 9 A

    '1''2#% 7

    A

    'T31;1NGKI=K

  • 7/31/2019 Summary Maulik Siddhant

    31/46

    31

    $C 'JL*JZ$%3

    $%1,663.$

    4 $.&AC$%

    ,$J*J/$%3'$&A

    0M0M0M0M

    BBN[F["";1BBN[F["";1BBN[F["";1BBN[F["";1****1111****0L=/L>#$'[email protected],0L=/L>#$'[email protected],0L=/L>#$'[email protected],0L=/L>#$'[email protected],

    ][3b%$$%][3b%$$%][3b%$$%][3b%$$%&;P##>&;P##>&;P##>&;P##>

    #6122#6122#6122#6122

    ()*#%1

    ($%*,)-

    '''' (0II0

    $%H $%,# .E, 6 .E, ]

    [3 b% O 7 ._ C $'D

    12 A [3 b% [ 8 C E A (

    BBN [F [ "" # C $8 $18 8

    7b+'A.E,]$%:'e.'

    3$ $ 3 7 ' N : 8

    [3b%F%$%8(C1

    A1$) 76$& .$

    12.$:$66 3'

    $%A

  • 7/31/2019 Summary Maulik Siddhant

    32/46

    32

    $%@ B" I [.E, ;1*1* 0L=/Z> \ .'

    3$]

    B,"K;.E,]\.'3$>

    'TI%0,3,

    ]0D;%>J,3,

    $%J; >

    B"6B," $%&E$%

    ,,,,Total lipid 2.11% 0.09%

    HDL 0.88% 0.77%

    LDL 2.22% 4.47%VLDL 6% 7.28%

    Serum cholestrol 3.42% 3.42%

    Serum triglyceride 5% 4.77%

    $ 7 $ E7 @

    $%56

    b @@ [ $% $ [3b%.2$GA

    6E$%5$ :P#[3b%A

    .E,] [3b% & .E,$&W9'PA

    :1$$ O6 $%$& $.E,]$

    A

  • 7/31/2019 Summary Maulik Siddhant

    33/46

    33

    0Z0Z0Z0Z

    1:HH@1:HH@1:HH@1:HH@1'&26 ?$1'&26 ?$1'&26 ?$1'&26 ?$

    $&$&$&$&

    ()*

    ($%*,)-

    '''' (0II0

    ,#'1.!

    HH@1':' $$% &A 3$% HH@1'.$ A 3 2$GHH@1'2,A ?$HH@1'$&.O7A$%H$%,#HH@,'

    .2$ AC6

    1898'D%8'Db.$`$%7D

    ,6.: 6D $%5@ ?$ O ' H$'D $%

    A

    $?$$33 '$2

    $H@ 'D76.$'DHH@1'.$

    $H@ ,d- C A C E!

    $ HH@ 3 8 $ H@ C @1 $ F% ] 3

    A C .O7 .$ HH@ @@

    122'D2$ A ##H@ C

  • 7/31/2019 Summary Maulik Siddhant

    34/46

    34

    $% 12 ?$ 3 8 @$ # ?$

    .O7..$ 4$% ?$$

    $ & 8 C E! 'P

    HH@63 2$G3A

    0/0/0/0/

    BBaQ1b2$1!""$'D!@a%4BBaQ1b2$1!""$'D!@a%4BBaQ1b2$1!""$'D!@a%4BBaQ1b2$1!""$'D!@a%4

    $$$$$$$$%&6%&6%&6%&6

    ()*

    ($%*,)-

    ()*

    '''' (0IIJ

    8 ' .O7 T2 ?$

    A^31.T @8#8

    $' A C ._ 'D 7 6

    HT :$O$4 O 3

    C$%,#A

    C $%,# $

    @ , $ 8

    $ 8 'P $ 8 %! $ %

    $ $)- $ $% $& O

    A

    E$ 6 ' % $

    'D$ $ % 'D8

    'D8 $% ;H@3> 3 A .'

    'P%4N2 $%A

  • 7/31/2019 Summary Maulik Siddhant

    35/46

    35

    JIJIJIJI

    #2'D!N1$%2#2'D!N1$%2#2'D!N1$%2#2'D!N1$%2

    ()*

    ($%*,)-

    '''' (0IIJ

    3 .' D,6 3 4

    # $&4$6.%A #12

    612'2,3ACH&,

    $%,#@1$%52

    A

    1 J 3@LL

    ,66A

    C Hypoglycemic tab. @1 6

    $@$@A , C Insulin 9 1 6

    $@$@A

    C T 1 6 $@$@

    A

    '1;>

    FD%4* )$T;'9>0* 3E,,3J* ,3

  • 7/31/2019 Summary Maulik Siddhant

    36/46

    36

    K* ,,3L* ,,[M* PZ*

    @,3

    /* %H@W3I* [,3*,,30*$TC'%4 T1,A

    'TKK%$%(8

    $.'3$%0

    %$&$ K*

  • 7/31/2019 Summary Maulik Siddhant

    37/46

    37

    $%@B"I $1$#;1NG0K=0>

    ') $ 0I % ' , :@ $ @

    #h88'8A

    B," I $1 $# @

    H :@ ;1NG 0K=K> I %' , :@ \ 6)

    H K ** $%(8 A ' $% /I

    A

    B" &%.$JM*L$%3 O$

    9 A, &%.$KI*J$%3

    9 AB"'$1$# B,"'$1$#H:@

    A

    J0J0J0J0

    BBBBBBBBTH@]D("TH@]D("TH@]D("TH@]D("""""$$%&'D$$%&'D$$%&'D$$%&'D%TH@&2%TH@&2%TH@&2%TH@&2

    ()*.

    ($%*,)-

    '''' (0IIJ

    18 9 $% 1 $ @!$@! %@ 1 6

    $%1$%6A3',.2'D'H3% @

    .$`C 8 ..!F' ' A BBTH@ ]D("" 'D%8 TH@ ' .

    @@$($%H@$,#'1

    A

  • 7/31/2019 Summary Maulik Siddhant

    38/46

    38

    $%@?$ 'D %8 TH@ 9'P 6

    $% A 3282T#% @1

    89'DbTH@1 $#

    @@$($%H@$$%A

    2T# 'D%8

    . 'D% TH@ ' 1 4H@8 N,8

    7, :6?$ .$A

    ( ]D 1 'D% TH@8 18

    96'Db8TH@69'PA

    JJJJJJJJ

    H?$6#21H?$6#21H?$6#21H?$6#21

    ()*

    ($%*,)-

    '''' (0IIJ

    2].2$ 6$%(

    %4 [ $% A

    H?$:cC'$1#

    ,#C'1A

    $%12 2 .$`,

    ' 6 @ '?$ H1@C2E.$H@$%

    $$%7,#A

  • 7/31/2019 Summary Maulik Siddhant

    39/46

    39

    $%,#''216 $%5

    H?$ $% $ 'D C A ] $ 3

    ?$ 669 83A$%16

    H?$ 6%4 %

    3.1A

    Maulik SiddhantJ

  • 7/31/2019 Summary Maulik Siddhant

    40/46

    40

    JKJKJKJK

    11116^' 126^' 126^' 126^' 12

    6..$6..$6..$6..$

    ()*3.$

    ($%*,)-

    '''' (0II

  • 7/31/2019 Summary Maulik Siddhant

    41/46

    41

    JLJLJLJL

    1g'21g'21g'21g'2

    ()*

    ($%*!$%.$

    '''' (0II 1 #2 6

    %A

    ;> 12$2 A

    ;> .$: $ &2

    ..$A

    # 4$$^

  • 7/31/2019 Summary Maulik Siddhant

    42/46

    42

    JMJMJMJM

    BB'1BB'1BB'1BB'17$'$7$'$7$'$7$'$"";1"";1"";1"";1****1111****=J=J>1g#=J=J>1g#=J=J>1g#=J=J>1g#

    6$%6$%6$%6$% ()*

    ($%*!$%.$

    '''' (0IIK

    'D 4:2 F : E$# @ 8 #

    ?$%A$%,38

    3%.$%,#3A

    CN BB' 17$'$"";1*1*=J=J>1:2

    $'D!@%4 12#7$'$ $%

    #6$ % ,#._A

    # 1 7 6 ,OH@

    H@$#4:183# J :

    BB"" ,OH@;

    BB"" H@;0JI'>

    $%2JI4:1A

    7$'$$%&;)-88 :, > @ ;, $` $& IQ> @

    $&;sub test>3CA

    '7$'$8

    7$'$F2

  • 7/31/2019 Summary Maulik Siddhant

    43/46

    43

    %#@1*1*=J=J

    B"7$'$3 **$%(6J

    3,CC8B,"6B"7$'$F2$%(6

    665;$%5290 *%*'>J

    3CA

    $ ?$ ' $1! , $` ;IQ> $

    $%J*LM$%@$&;sub test>$%5$K*

    KI$%A66%@$$%>>>$'D!@:1#$$'D!@:1#$$'D!@:1#$$'D!@:1#$

    '2'2'2'2

    ()*$%

    ($%*!$%.$

    '''' (0IIK

    ' HT 4$%5

    . ,d- $H@ % A $

    633C$%#:7)

    4#3' 2$#4 1#4CA

    7#,676'%4

    # $% ,O # $ % .$ 3

    '$%&,H$'D?$'D1A

    '76:2$%'3

    4 BB4:$%'3(""$'D6:1#$

  • 7/31/2019 Summary Maulik Siddhant

    44/46

    44

    126,U#?$ $%: '?$

    1A

    B"B,",B" 0I

    $% @ 1?$ 6,U$% @$?$ '

    C6B,"0I,U$@'3

    CA

    ':1#$;8.G7)=/>

    T#$%@K%0,3@@,U

    $@&1?$',3$%A

    '$%07C

    '$% B" KM*KL$%6

    B,"

  • 7/31/2019 Summary Maulik Siddhant

    45/46

    45

    ' .$ ,# ' 1

    A

    1$# 6 C $%

    ;B"B,">:$%2JJ 7A

    $%2T1';18TH@

    0T$%(83$0'$%

    3CA

    12$ 6 12$1!X-ray KUB region6

    USG $&3CA

    X-ray $&(KUB) $%5$(

    ;> B" K $ 8

    @ 'A

    ;0> B," 12$X-ray KUB region

    'DC@A

    USG $&$%5$(

    ;> B" K $ 8 J 80 @7CA

    ;0> B,"J $8J 86

    A

    B,"J 012216

    @

  • 7/31/2019 Summary Maulik Siddhant

    46/46

    AC$%$%&

    % $ &$ B" # ;@B," ;KJ*L837'D!& @A